Title: Biologicals in the era of biosimilars: implications for naming and prescribing
Authors: Declerck, Paul # ×
Issue Date: Jan-2007
Series Title: European Journal of Hospital Pharmacy Practice vol:13 issue:1 pages:51-53
Abstract: Unlike generics of chemical drugs,
biosimilars are similar but not identical
to the original product. Therefore, and in
relation to their safe use and pharmacovigilance,
questions are being raised
about the (im)possibility of applying the
current INN system for adequate naming
of biotherapeutics in general and biosimilars
in particular. Should biosimilars
have distinct INNs or should a new independent
naming system be developed?
What measures should be taken to
ensure that healthcare professionals
realise that biosimilars should not be
merely considered as copies, and thus
that the patient may react differently
upon substitution? Does the approach of
naming have an impact on prescribing
ISSN: 1781-9989
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Laboratory for Pharmaceutical Biology (-)
× corresponding author
# (joint) last author

Files in This Item:
File Description Status SizeFormat
Declerck EJHP 2007.pdfmain article Published 138KbAdobe PDFView/Open


All items in Lirias are protected by copyright, with all rights reserved.